📰 Adv Chronic News
Adv Chronic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adv Chronic. Real-time updates on events, politics, business and more.
November 1, 2023
Dr Cormac F Mullins - Consultant in Anaesthesia and Pain Medicine Cork University Hospital discusses the challenge of managing pain in general practice and demonstrates strategies in four case studies
June 28, 2023
Achlorhydria is a condition where there is complete absence or reduced secretion of hydrochloric acid in the gastric juices.
May 3, 2023
Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.
March 16, 2023
An estimated 65 million people worldwide have moderate or severe chronic obstructive pulmonary disease (COPD), an umbrella term used to...
November 15, 2022
What exactly leads to Diabetes?
February 11, 2022
Neurology experts Drs Lavanya Visvabharathy, Anna Cervantes-Arslanian, and Jonathan Rogers discuss the mild to severe neurologic symptoms of long-haul COVID.
January 19, 2022
Artizan Biosciences Selects Lead Product Candidate for Inflammatory Bowel Disease Therapeutic Development Program - read this article along with other careers information, tips and advice on BioSpace
January 18, 2022
NEW HAVEN, Conn., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc. (“Artizan”), a precision medicine biotechnology company, today announced the selection of its lead product candidate, ARZC-001, for the
December 20, 2021
Ad hoc announcement pursuant to Art. 53 LR Ligelizumab, a high-affinity anti-IgE antibody, demonstrated superiority compared with placebo at Week 12 in Phase III PEARL 1 and PEARL 2 trials, but not